{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:45:39Z","timestamp":1791290739086,"version":"4.3.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"GW Pharmaceuticals, now a part of Jazz Pharmaceuticals, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics Open"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s41669-023-00387-1","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T19:19:58Z","timestamp":1675970398000},"page":"299-312","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The Burden of Caring for Individuals with Tuberous Sclerosis Complex (TSC) Who Experience Epileptic Seizures: A Descriptive UK Survey"],"prefix":"10.1007","volume":"7","author":[{"given":"Hanna","family":"Skrobanski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishan","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6918-2936","authenticated-orcid":false,"given":"Sally","family":"Bowditch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Hubig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Dziadulewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Fish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Takhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siu Hing","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,9]]},"reference":[{"key":"387_CR1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1001\/archneur.1994.00540130110018","volume":"51","author":"G Ahls\u00e9n","year":"1994","unstructured":"Ahls\u00e9n G, Gillberg IC, Lindblom R, Gillberg C. Tuberous sclerosis in Western Sweden: a population study of cases with early childhood onset. Arch Neurol. 1994;51:76\u201381. https:\/\/doi.org\/10.1001\/archneur.1994.00540130110018.","journal-title":"Arch Neurol"},{"key":"387_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1469-8749.1996.tb12086.x","volume":"38","author":"DW Webb","year":"1996","unstructured":"Webb DW, Fryer AE, Osborne JP. Morbidity associated with tuberous sclerosis: a population study. Dev Med Child Neurol. 1996;38:146\u201355. https:\/\/doi.org\/10.1111\/j.1469-8749.1996.tb12086.x.","journal-title":"Dev Med Child Neurol"},{"key":"387_CR3","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/S0140-6736(05)78872-3","volume":"351","author":"FJ O\u2019Callaghan","year":"1998","unstructured":"O\u2019Callaghan FJ, Shiell AW, Osborne JP, Martyn CN. Prevalence of tuberous sclerosis estimated by capture-recapture analysis. Lancet. 1998;351:1490. https:\/\/doi.org\/10.1016\/S0140-6736(05)78872-3.","journal-title":"Lancet"},{"key":"387_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1469-8749.2006.tb01302.x","volume":"48","author":"LA Devlin","year":"2006","unstructured":"Devlin LA, Shepherd CH, Crawford H, Morrison PJ. Tuberous sclerosis complex: clinical features, diagnosis, and prevalence within Northern Ireland. Dev Med Child Neurol. 2006;48:495\u20139. https:\/\/doi.org\/10.1111\/j.1469-8749.2006.tb01302.x.","journal-title":"Dev Med Child Neurol"},{"key":"387_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.seizure.2017.10.005","volume":"53","author":"K-O Welin","year":"2017","unstructured":"Welin K-O, Carlqvist P, Svensson A, Althin R, Eklund E, Rask O. Epilepsy in tuberous sclerosis patients in Sweden\u2014healthcare utilization, treatment, morbidity, and mortality using national register data. Seizure. 2017;53:4\u20139. https:\/\/doi.org\/10.1016\/j.seizure.2017.10.005.","journal-title":"Seizure"},{"key":"387_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13023-019-1258-3","volume":"15","author":"JP Z\u00f6llner","year":"2020","unstructured":"Z\u00f6llner JP, Franz DN, Hertzberg C, Nabbout R, Rosenow F, Sauter M, et al. A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC). Orphanet J Rare Dis. 2020;15:23. https:\/\/doi.org\/10.1186\/s13023-019-1258-3.","journal-title":"Orphanet J Rare Dis"},{"key":"387_CR7","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.yebeh.2007.07.010","volume":"11","author":"DA Muzykewicz","year":"2007","unstructured":"Muzykewicz DA, Newberry P, Danforth N, Halpern EF, Thiele EA. Psychiatric comorbid conditions in a clinic population of 241 patients with tuberous sclerosis complex. Epilepsy Behav. 2007;11:506\u201313. https:\/\/doi.org\/10.1016\/j.yebeh.2007.07.010.","journal-title":"Epilepsy Behav"},{"key":"387_CR8","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1185\/03007995.2011.586687","volume":"27","author":"L Hallett","year":"2011","unstructured":"Hallett L, Foster T, Liu Z, Blieden M, Valentim J. Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review. Curr Med Res Opin. 2011;27:1571\u201383. https:\/\/doi.org\/10.1185\/03007995.2011.586687.","journal-title":"Curr Med Res Opin"},{"key":"387_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/epi4.12286","volume":"4","author":"R Nabbout","year":"2018","unstructured":"Nabbout R, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, et al. Epilepsy in tuberous sclerosis complex: findings from the TOSCA study. Epilepsia Open. 2018;4:73\u201384. https:\/\/doi.org\/10.1002\/epi4.12286.","journal-title":"Epilepsia Open"},{"key":"387_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2021.07.011","volume":"123","author":"H Northrup","year":"2021","unstructured":"Northrup H, Aronow ME, Bebin EM, Bissler J, Darling TN, de Vries PJ, et al. Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations. Pediatr Neurol. 2021;123:50\u201366. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2021.07.011.","journal-title":"Pediatr Neurol"},{"key":"387_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.pediatrneurol.2019.12.016","volume":"106","author":"A Gupta","year":"2020","unstructured":"Gupta A, de Bruyn G, Tousseyn S, Krishnan B, Lagae L, Agarwal N, et al. Epilepsy and neurodevelopmental comorbidities in tuberous sclerosis complex: a natural history study. Pediatr Neurol. 2020;106:10\u20136. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2019.12.016.","journal-title":"Pediatr Neurol"},{"key":"387_CR12","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/dmcn.14356","volume":"62","author":"C Tye","year":"2020","unstructured":"Tye C, Mcewen FS, Liang H, Underwood L, Woodhouse E, Barker ED, et al. Long-term cognitive outcomes in tuberous sclerosis complex. Dev Med Child Neurol. 2020;62:322\u20139. https:\/\/doi.org\/10.1111\/dmcn.14356.","journal-title":"Dev Med Child Neurol"},{"key":"387_CR13","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/epi4.12365","volume":"4","author":"M Vergeer","year":"2019","unstructured":"Vergeer M, Ranitz-Greven WL, Neary MP, Ionescu-Ittu R, Emond B, Sheng Duh M, et al. Epilepsy, impaired functioning, and quality of life in patients with tuberous sclerosis complex. Epilepsia Open. 2019;4:581\u201392. https:\/\/doi.org\/10.1002\/epi4.12365.","journal-title":"Epilepsia Open"},{"issue":"Suppl. 3","key":"387_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.09.2088","volume":"21","author":"B Bennett","year":"2018","unstructured":"Bennett B, Cooper A, Fladrowski C, Evanochko C, Neary MP, Vieira J, et al. Patient and caregiver web-based survey: health utilities in tuberous sclerosis complex (TSC) patient population. Value Health. 2018;21(Suppl. 3):S349 (Abstract PND123). https:\/\/doi.org\/10.1016\/j.jval.2018.09.2088.","journal-title":"Value Health"},{"issue":"Suppl. 3","key":"387_CR15","volume":"59","author":"B Bennett","year":"2018","unstructured":"Bennett B, Cooper A, Fladrowski C, Evanochko C, Neary M, Vieira J, et al. Assessing quality of life (QOL) in patients with seizures associated with tuberous sclerosis complex (TSC). Epilepsia. 2018;59(Suppl. 3):S331\u20132 (Abstract p724).","journal-title":"Epilepsia"},{"key":"387_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.yebeh.2018.11.021","volume":"92","author":"T Tritton","year":"2019","unstructured":"Tritton T, Bennett B, Brohan E, Grant L, Cooper A, Fladrowski C, et al. Health utilities and quality of life in individuals with tuberous sclerosis complex (TSC) who experience epileptic seizures: a web-based survey. Epilepsy Behav. 2019;92:213\u201320. https:\/\/doi.org\/10.1016\/j.yebeh.2018.11.021.","journal-title":"Epilepsy Behav"},{"key":"387_CR17","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","volume":"363","author":"DA Krueger","year":"2010","unstructured":"Krueger DA, Care MM, Holland K, Agricola K, Tudor C, Mangeshkar P, et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med. 2010;363:1801\u201311. https:\/\/doi.org\/10.1056\/NEJMoa1001671.","journal-title":"N Engl J Med"},{"key":"387_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pediatrneurol.2010.03.003","volume":"43","author":"N Zamponi","year":"2010","unstructured":"Zamponi N, Petrelli C, Passamonti C, Moavero R, Curatolo P. Vagus nerve stimulation for refractory epilepsy in tuberous sclerosis. Pediatr Neurol. 2010;43:29\u201334. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2010.03.003.","journal-title":"Pediatr Neurol"},{"key":"387_CR19","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1111\/j.1528-1167.2010.02669.x","volume":"51","author":"S Liang","year":"2010","unstructured":"Liang S, Li A, Zhao M, Jiang H, Yu S, Meng X, et al. Epilepsy surgery in tuberous sclerosis complex: emphasis on surgical candidate and neuropsychology. Epilepsia. 2010;51:2316\u201321. https:\/\/doi.org\/10.1111\/j.1528-1167.2010.02669.x.","journal-title":"Epilepsia"},{"key":"387_CR20","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1007\/s00415-017-8507-y","volume":"264","author":"S Liang","year":"2017","unstructured":"Liang S, Zhang J, Yang Z, Zhang S, Cui Z, Cui J, et al. Long-term outcomes of epilepsy surgery in tuberous sclerosis complex. J Neurol. 2017;264:1146\u201354. https:\/\/doi.org\/10.1007\/s00415-017-8507-y.","journal-title":"J Neurol"},{"key":"387_CR21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.yebeh.2010.11.003","volume":"20","author":"J Roth","year":"2011","unstructured":"Roth J, Olasunkanmi A, MacAllister WS, Weil E, Uy CC, Devinsky O, et al. Quality of life following epilepsy surgery for children with tuberous sclerosis complex. Epilepsy Behav. 2011;20:561\u20135. https:\/\/doi.org\/10.1016\/j.yebeh.2010.11.003.","journal-title":"Epilepsy Behav"},{"key":"387_CR22","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1093\/brain\/awz411","volume":"143","author":"S Liu","year":"2020","unstructured":"Liu S, Yu T, Guan Y, Zhang K, Ding P, Chen L, et al. Resective epilepsy surgery in tuberous sclerosis complex: a nationwide multicentre retrospective study from China. Brain. 2020;143:570\u201381. https:\/\/doi.org\/10.1093\/brain\/awz411.","journal-title":"Brain"},{"key":"387_CR23","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1177\/0883073815575364","volume":"30","author":"AM Rentz","year":"2015","unstructured":"Rentz AM, Skalicky AM, Pashos CL, Liu Z, Magestro M, Pelletier CL, et al. Caring for children with tuberous sclerosis complex: what is the physical and mental health impact on caregivers? J Child Neurol. 2015;30:1574\u201381. https:\/\/doi.org\/10.1177\/0883073815575364.","journal-title":"J Child Neurol"},{"key":"387_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejpn.2021.10.003","volume":"35","author":"LM Willems","year":"2021","unstructured":"Willems LM, Schubert-Bast S, Grau J, Hertzberg C, Kurlemann G, Wiemer-Kruel A, et al. Health-related quality of life in children and adolescents with tuberous sclerosis complex and their caregivers: a multicentre cohort study from Germany. Eur J Paediatr Neurol. 2021;35:111\u201322. https:\/\/doi.org\/10.1016\/j.ejpn.2021.10.003.","journal-title":"Eur J Paediatr Neurol"},{"key":"387_CR25","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/jir.12609","volume":"63","author":"A McDonald","year":"2019","unstructured":"McDonald A, Goodwin J, Roberts S, Fish L, Vaughan B, Cooper A, et al. \u201cWe\u2019ve made the best of it. But we do not have a normal life\u201d: families\u2019 experiences of tuberous sclerosis complex and seizure management. J Intellect Disabil Res. 2019;63:947\u201356. https:\/\/doi.org\/10.1111\/jir.12609.","journal-title":"J Intellect Disabil Res"},{"key":"387_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003707","volume":"3","author":"G Graffigna","year":"2013","unstructured":"Graffigna G, Bosio C, Cecchini I. Assisting a child with tuberous sclerosis complex (TSC): a qualitative deep analysis of parents\u2019 experience and caring needs. BMJ Open. 2013;3:e003707. https:\/\/doi.org\/10.1136\/bmjopen-2013-003707.","journal-title":"BMJ Open"},{"key":"387_CR27","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.yebeh.2008.05.010","volume":"13","author":"CM Kopp","year":"2008","unstructured":"Kopp CM, Muzykewicz DA, Staley BA, Thiele EA, Pulsifer MB. Behavior problems in children with tuberous sclerosis complex and parental stress. Epilepsy Behav. 2008;13:505\u201310. https:\/\/doi.org\/10.1016\/j.yebeh.2008.05.010.","journal-title":"Epilepsy Behav"},{"key":"387_CR28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s13023-021-01899-x","volume":"16","author":"J Grau","year":"2021","unstructured":"Grau J, Z\u00f6llner JP, Schubert-Bast S, Kurlemann G, Hertzberg C, Wiemer-Kruel A, et al. Direct and indirect costs and cost-driving factors of Tuberous sclerosis complex in children, adolescents, and caregivers: a multicenter cohort study. Orphanet J Rare Dis. 2021;16:282. https:\/\/doi.org\/10.1186\/s13023-021-01899-x.","journal-title":"Orphanet J Rare Dis"},{"key":"387_CR29","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1080\/13696998.2018.1487447","volume":"21","author":"AM Skalicky","year":"2018","unstructured":"Skalicky AM, Rentz AM, Liu Z, Said Q, Nakagawa JA, Frost MD, et al. Economic burden, work, and school productivity in individuals with tuberous sclerosis and their families. J Med Econ. 2018;21:953\u20139. https:\/\/doi.org\/10.1080\/13696998.2018.1487447.","journal-title":"J Med Econ"},{"key":"387_CR30","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.ejpn.2019.09.006","volume":"23","author":"S Amin","year":"2019","unstructured":"Amin S, Mallick AA, Lux A, O\u2019Callaghan F. Quality of life in patients with tuberous sclerosis complex (TSC). Eur J Paediatr Neurol. 2019;23:801\u20137. https:\/\/doi.org\/10.1016\/j.ejpn.2019.09.006.","journal-title":"Eur J Paediatr Neurol"},{"key":"387_CR31","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1136\/archdischild-2018-316394","volume":"104","author":"CY Fong","year":"2019","unstructured":"Fong CY, Ng K, Kong AN, Ong LC, Rithauddin MA, Thong MK, et al. Quality of life of children with tuberous sclerosis complex. Arch Child. 2019;104:972\u20138. https:\/\/doi.org\/10.1136\/archdischild-2018-316394.","journal-title":"Arch Child"},{"key":"387_CR32","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3389\/fneur.2020.00904","volume":"11","author":"AC Jansen","year":"2020","unstructured":"Jansen AC, Vanclooster S, de Vries PJ, Fladrowski C, Beaure d\u2019Aug\u00e8res G, Carter T, et al. Burden of illness and quality of life in tuberous sclerosis complex: findings from the TOSCA study. Front Neurol. 2020;11:904. https:\/\/doi.org\/10.3389\/fneur.2020.00904.","journal-title":"Front Neurol"},{"key":"387_CR33","unstructured":"NHS. Introduction to care and support. 2018. https:\/\/www.nhs.uk\/conditions\/social-care-and-support-guide\/introduction-to-care-and-support\/. Accessed 2 Nov 2022."},{"key":"387_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1477-7525-2-55","volume":"2","author":"JW Varni","year":"2004","unstructured":"Varni JW, Sherman SA, Burwinkle TM, Dickinson PE, Dixon P. The PedsQLTM\u00a0Family Impact Module: preliminary reliability and validity. Health Qual Life Outcomes. 2004;2:55. https:\/\/doi.org\/10.1186\/1477-7525-2-55.","journal-title":"Health Qual Life Outcomes"},{"key":"387_CR35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361\u201370. https:\/\/doi.org\/10.1111\/j.1600-0447.1983.tb09716.x.","journal-title":"Acta Psychiatr Scand"},{"key":"387_CR36","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2017. https:\/\/www.r-project.org\/ (accessed November 23, 2021)."},{"key":"387_CR37","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1007\/s11136-013-0422-9","volume":"22","author":"GR Medrano","year":"2013","unstructured":"Medrano GR, Berlin KS, Hobart DW. Utility of the PedsQLTM family impact module: assessing the psychometric properties in a community sample. Qual Life Res. 2013;22:2899\u2013907. https:\/\/doi.org\/10.1007\/s11136-013-0422-9.","journal-title":"Qual Life Res"},{"key":"387_CR38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1365-2214.2008.00927.x","volume":"35","author":"RL Hsieh","year":"2009","unstructured":"Hsieh RL, Huang HY, Lin MI, Wu CW, Lee W-C. Quality of life, health satisfaction and family impact on caregivers of children with developmental delays. Child Care Health Dev. 2009;35:243\u20139. https:\/\/doi.org\/10.1111\/j.1365-2214.2008.00927.x.","journal-title":"Child Care Health Dev"},{"key":"387_CR39","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/jpepsy\/jsp099","volume":"36","author":"KE Jastrowski Mano","year":"2011","unstructured":"Jastrowski Mano KE, Khan KA, Ladwig RJ, Weisman SJ. The impact of pediatric chronic pain on parents\u2019 health-related quality of life and family functioning: reliability and validity of the PedsQL 4.0 Family Impact Module. J Pediatr Psychol. 2011;36:517\u201327. https:\/\/doi.org\/10.1093\/jpepsy\/jsp099.","journal-title":"J Pediatr Psychol"},{"key":"387_CR40","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s11136-014-0763-z","volume":"24","author":"S Breeman","year":"2015","unstructured":"Breeman S, Cotton S, Fielding S, Jones GT. Normative data for the Hospital Anxiety and Depression Scale. Qual Life Res. 2015;24:391\u20138. https:\/\/doi.org\/10.1007\/s11136-014-0763-z.","journal-title":"Qual Life Res"},{"key":"387_CR41","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3389\/fneur.2019.01144","volume":"10","author":"R Marques","year":"2019","unstructured":"Marques R, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, et al. Treatment patterns and use of resources in patients with tuberous sclerosis complex: insights from the TOSCA registry. Front Neurol. 2019;10:1144. https:\/\/doi.org\/10.3389\/fneur.2019.01144.","journal-title":"Front Neurol"},{"key":"387_CR42","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1464-410X.2004.05046.x","volume":"94","author":"FJ O\u2019Callaghan","year":"2004","unstructured":"O\u2019Callaghan FJ, Noakes MJ, Martyn CN, Osborne JP. An epidemiological study of renal pathology in tuberous sclerosis complex. BJU Int. 2004;94:853\u20137. https:\/\/doi.org\/10.1111\/j.1464-410X.2004.05046.x.","journal-title":"BJU Int"},{"key":"387_CR43","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","volume":"70","author":"SK Rakowski","year":"2006","unstructured":"Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA. Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors. Kidney Int. 2006;70:1777\u201382. https:\/\/doi.org\/10.1038\/sj.ki.5001853.","journal-title":"Kidney Int"},{"key":"387_CR44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13023-016-0553-5","volume":"12","author":"JC Kingswood","year":"2017","unstructured":"Kingswood JC, d\u2019Aug\u00e8res GB, Belousova E, Ferreira JC, Carter T, Castellana R, et al. TuberOus SClerosis registry to increase disease Awareness (TOSCA)\u2014baseline data on 2093 patients. Orphanet J Rare Dis. 2017;12:2. https:\/\/doi.org\/10.1186\/s13023-016-0553-5.","journal-title":"Orphanet J Rare Dis"}],"container-title":["PharmacoEconomics - Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41669-023-00387-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41669-023-00387-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41669-023-00387-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T06:07:46Z","timestamp":1679897266000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41669-023-00387-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,9]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["387"],"URL":"https:\/\/doi.org\/10.1007\/s41669-023-00387-1","relation":{},"ISSN":["2509-4262","2509-4254"],"issn-type":[{"value":"2509-4262","type":"print"},{"value":"2509-4254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,9]]},"assertion":[{"value":"5 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was funded by GW Pharmaceuticals, now a part of Jazz Pharmaceuticals, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All authors met the International Committee of Medical Journal Editors (ICMJE) authorship criteria and had full access to relevant data. Neither honoraria nor payments were made for authorship. Sally Bowditch, Edward Dziadulewicz, and Kishan Vyas are employees of Jazz Pharmaceuticals, Inc. Sally Bowditch and Edward Dziadulewicz hold stock\/stock options in Jazz Pharmaceuticals, Inc. Hanna Skrobanski, Lena Hubig, and Siu Hing Lo are employees of Acaster Lloyd Consulting Ltd, which received payment from GW Pharmaceuticals, now a part of Jazz Pharmaceuticals, Inc., in the conduct of this study. Louise Fish is an employee of\u00a0Genetic Alliance UK and\u00a0was an employee of the Tuberous Sclerosis Association (TSA) when the study was conducted, and Pooja Takhar is an employee of the TSA; the TSA has received sponsorship for events, an unrestricted educational grant, and consulting fees from GW Pharmaceuticals, now a part of Jazz Pharmaceuticals, Inc.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study received ethical approval from the WIRB-Copernicus Group Independent Review Board (tracking number: 20211736).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants provided informed, written consent prior to participating in the survey, which included consent for participation in the survey and for anonymous data to be used in future publications.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"All relevant data are provided with the manuscript and supporting files. Jazz has established a process to review requests from qualified external researchers for data from Jazz-sponsored clinical trials in a responsible manner that includes protecting patient privacy, assurance of data security and integrity, and furthering scientific and medical innovation. Additional details on Jazz Pharmaceuticals\u2019 data-sharing criteria and process for requesting access can be found at: .","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"HS and SHL contributed to the conception\/design of the study. All authors contributed to the acquisition, analysis, or interpretation of data. All authors drafted or critically revised the manuscript for important intellectual content and approved the final version to be published. All authors agree to be accountable for all aspects of the work.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}